Massimo Pilli
Overview
Explore the profile of Massimo Pilli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cariani E, Pilli M, Barili V, Porro E, Biasini E, Olivani A, et al.
Oncoimmunology
. 2016 Sep;
5(8):e1154249.
PMID: 27622055
NK-cell number and function have been associated with cancer progression. A detailed analysis of phenotypic and functional characteristics of NK-cells in HCC is still lacking. NK-cell function is regulated by...
2.
Cariani E, Pilli M, Zerbini A, Rota C, Olivani A, Zanelli P, et al.
Clin Cancer Res
. 2013 Aug;
19(19):5465-73.
PMID: 23938290
Purpose: We evaluated the impact of the killer immunoglobulin-like receptors (KIR) of natural killer (NK) cells and of their HLA ligands over the clinical outcome of hepatitis C virus (HCV)-related...
3.
Soderholm J, Waldenstrom J, Askarieh G, Pilli M, Bochud P, Negro F, et al.
PLoS One
. 2013 Feb;
8(2):e56991.
PMID: 23437290
Background: Interferon and ribavirin therapy for chronic hepatitis C virus (HCV) infection yields sustained virological response (SVR) rates of 50-80%. Several factors such as non-1 genotype, beneficial IL28B genetic variants,...
4.
Cariani E, Pilli M, Zerbini A, Rota C, Olivani A, Pelosi G, et al.
PLoS One
. 2012 Mar;
7(3):e32493.
PMID: 22396772
The definition of the risk of hepatocellular carcinoma (HCC) recurrence after resection represents a central issue to improve the clinical management of patients. In this study we examined the prognostic...
5.
Missale G, Pilli M, Zerbini A, Penna A, Ravanetti L, Barili V, et al.
Gut
. 2012 Feb;
61(7):1076-84.
PMID: 22337949
Background: Hepatitis C virus (HCV) persistence is associated with impaired CD8 functions. Whether functional restoration of CD8 T cells chronically exposed to antigen can be obtained once the antigen is...
6.
Zerbini A, Pilli M, Laccabue D, Pelosi G, Molinari A, Negri E, et al.
Gastroenterology
. 2010 Jan;
138(5):1931-42.
PMID: 20060829
Background & Aims: Radiofrequency thermal ablation (RFA) is a minimally invasive technique used as standard local therapy of hepatocellular carcinoma and second-line treatment for metastatic liver tumors. Studies in preclinical...
7.
Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, et al.
Gastroenterology
. 2008 Mar;
134(5):1470-81.
PMID: 18355815
Background & Aims: Hepatitis B virus (HBV) DNA detection in serum and/or in the liver of hepatitis B surface antigen (HBsAg)-negative patients with or without serologic markers of previous viral...
8.
Zerbini A, Pilli M, Fagnoni F, Pelosi G, Pizzi M, Schivazappa S, et al.
J Immunother
. 2008 Mar;
31(3):271-82.
PMID: 18317360
Radiofrequency thermal ablation represents an effective treatment for hepatocellular carcinoma (HCC) and it can also exert an "adjuvant" effect on spontaneous antitumor T-cell responses, as suggested by human and animal...
9.
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)
Pilli M, Zerbini A, Penna A, Orlandini A, Lukasiewicz E, Pawlotsky J, et al.
Gastroenterology
. 2007 Oct;
133(4):1132-43.
PMID: 17919489
Background & Aims: The second slope of viral decline induced by interferon treatment has been suggested to be influenced mainly by the hepatitis C virus (HCV)-specific T-cell response; however, this...
10.
Penna A, Pilli M, Zerbini A, Orlandini A, Mezzadri S, Sacchelli L, et al.
Hepatology
. 2007 Feb;
45(3):588-601.
PMID: 17326153
Unlabelled: The functional impairment of HCV-specific T cell responses is believed to be an important determinant of HCV persistence, but the functional T cell defects of patients with chronic hepatitis...